Investing Profile

Hongbo Lu

InvestorVC

Managing Partner at Vivo Capital

vivocapital.com/team/hongbo-l...Palo Alto, California

‌

‌

‌

Your Intro Paths to Hongbo Lu

‌

‌

‌

‌

‌

‌

‌

‌

‌

‌

‌

‌

Find Hongbo Lu on

cb

Current Investing Position

Vivo Capital Partner

Investment Range

$10.0M - $50.0M

Sweet Spot

$25.0M

Investments On Record

10

Current Fund Size

$1.4B

Hongbo Lu is on these Sector & Stage Rankings

Pharmaceuticals (Seed)BioTech (Seed)Pharmaceuticals (Series A)BioTech (Series A)Health IT (Series A)Health & Hospital Services (Series A)San Francisco Bay Area Health IT (Seed)Digital Health (Series A)Digital Health (Seed)Health & Hospital Services (Seed)

Hongbo Lu's Investments On Record (8)

Company	StageDateRound Size	Total Raised
Ronovo Surgical	Series BAug 2023$27M	$27M
Rgenta Therapeutics	Series ANov 2022$52M SeedMay 2021$18M	$90M
Co-investors: Fei Shen (Boehringer Ingelheim Venture Fund), Martin Heidecker (AMR Action Fund)
Zenas BioPharma	Series BNov 2022$120M	$320M
Co-investors: Jake Nunn (SR One Capital Management)
Visirna Therapeutics	SeedApr 2022$60M	$60M
Co-investors: Gaurav Aggarwal (Vivo Capital)
Avistone Pharmaceuticals	Series ADec 2021$200M	$200M
Ablaze Pharmaceuticals	Series ANov 2021$75M	$75M
Co-investors: Aaron Royston (venBio)
Avedro	Series FMay 2018$25M Series ENov 2015$32M	$150M
Co-investors: Doug Cole (Flagship Ventures), Phil Ferneau (Borealis Ventures), David Berry (Flagship Ventures), Bruce Cleveland (Wildcat Ventures), Gil Kliman (InterWest)
Turning Point Therapeutics	Series CMay 2017$45M	$130M
Co-investors: Carl Gordon (OrbiMed), Chandra Leo (Hbm Partners), Simeon J. George (SR One)

Investors who invest with Hongbo Lu